GlassScriptPhysician profile
David A Miller
NPI 1710941117
$20,229.71
in general payments reported to CMS, 2019-2025
51 companies · $2,107 in 2025
The $2,107 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,271 · 2020: $3,178 · 2021: $1,713 · 2022: $6,165 · 2023: $2,543 · 2024: $2,254 · 2025: $2,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,543 · Education: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,542.86 |
| Education | $360.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,185.96 | 2019-2025 | Ams 800 Artificial Urinary Sphincter, Advance Xp, Lumenis Pulse 120h |
| Abbvie INC. | $1,536.01 | 2022-2025 | |
| Astellas Pharma US INC | $1,527.39 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $1,058.42 | 2019-2025 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $1,043.17 | 2019-2025 | Provenge |
| Blue Earth Diagnostics | $850.91 | 2019-2025 | Posluma |
| Sumitomo Pharma America, INC. | $845.52 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $608.04 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $451.23 | 2019-2024 | Xiaflex, Aveed, Edex |
| Amgen INC. | $309.79 | 2019-2022 | |
| Neotract INC. | $301.75 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $299.62 | 2022-2025 | |
| Urogen Pharma, INC. | $290.50 | 2020-2025 | Jelmyto |
| Pfizer INC. | $276.57 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $276.00 | 2023-2025 | Pylarify |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $253.77 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $252.75 | 2020-2025 | Keytruda, Welireg, Lynparza |
| Teleflex LLC | $237.28 | 2021-2025 | Barrigel |
| Axonics, INC. | $186.58 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $181.29 | 2019 | |
| Clarus Therapeutics INC. | $178.95 | 2020-2021 | |
| Accord Healthcare, INC. | $173.97 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $156.59 | 2022-2025 | Lynparza |
| Urovant Sciences INC | $154.83 | 2021-2022 | |
| Procept Biorobotics Corporation | $153.01 | 2024-2025 | Aquabeam System |
| Antares Pharma, INC. | $146.87 | 2019-2025 | Xyosted |
| Calyxo, INC. | $146.62 | 2025 | Cvac Aspiration System |
| Rochester Medical Corporation | $121.96 | 2019-2022 | |
| Allergan, INC. | $115.06 | 2019-2021 | |
| Ambu INC. | $99.83 | 2022-2024 | |
| Ferring Pharmaceuticals INC. | $96.26 | 2019-2025 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $85.18 | 2022-2023 | Yonsa |
| Endo USA, INC. | $83.97 | 2024-2025 | Xiaflex, Aveed |
| Ethicon US, LLC | $58.40 | 2021-2023 | Echelon Flex |
| Bard Access Systems, INC. | $56.83 | 2019 | |
| Tempus Ai, INC | $54.81 | 2024 | Xt Cdx |
| Olympus America INC. | $41.74 | 2025 | Itind System |
| Foundation Medicine, INC. | $36.67 | 2021 | |
| Intuitive Surgical, INC. | $36.37 | 2019 | |
| Mission Pharmacal Company | $33.71 | 2020 | |
| Travere Therapeutics, INC. | $30.81 | 2019-2020 | |
| Bioprotect Medical, INC. | $28.95 | 2025 | Bioprotect Balloon Implant System |
| Halozyme INC | $24.52 | 2023 | |
| Laborie Medical Technologies Corp. | $23.17 | 2024 | Endosheath Technology |
| Cycle Pharmaceuticals INC | $22.30 | 2024 | Tiopronin |
| Photocure INC | $19.33 | 2019 | |
| Cardinal Health 414 LLC | $18.89 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.08 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $13.90 | 2023 | Bard Urinary Drainage Bag |
| Therapeuticsmd, INC. | $13.52 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.